Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Thrombosis? 299 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 299 reports of Thrombosis have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.8% of all adverse event reports for CABOZANTINIB S-MALATE.

299
Reports of Thrombosis with CABOZANTINIB S-MALATE
0.8%
of all CABOZANTINIB S-MALATE reports
17
Deaths
155
Hospitalizations

How Dangerous Is Thrombosis From CABOZANTINIB S-MALATE?

Of the 299 reports, 17 (5.7%) resulted in death, 155 (51.8%) required hospitalization, and 3 (1.0%) were considered life-threatening.

Is Thrombosis Listed in the Official Label?

Yes, Thrombosis is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Thrombosis?

LENALIDOMIDE (6,433) APIXABAN (5,298) RIVAROXABAN (3,220) ADALIMUMAB (2,334) POMALIDOMIDE (1,158) TOFACITINIB (1,143) RITUXIMAB (1,083) ETANERCEPT (1,051) METHOTREXATE (981) PREDNISONE (963)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Thrombosis Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Thrombosis Reports All Drugs Causing Thrombosis CABOZANTINIB S-MALATE Demographics